To the content
2 . 2022

Effects of low-dose aspirin combined with vitamin e on the incidence of intrauterine growth restriction and hemorheological indexes of pregnant women in patients with gestational hypertension

Abstract

Aim. To investigate the effect of low-dose aspirin combined with vitamin E on the incidence of intrauterine growth restriction and hemorheological indexes of pregnant women in patients with gestational hypertension.

Method. 134 elderly patients with chronic urticaria treated in our hospital from November 2017 to November 2020 were studied. According to the treatment methods, they were randomly divided into observation and control groups. There were 67 patients in the observation group, aged 20–37 years, with an average of (25.7±2.75) years. There were 67 patients in the control group, aged 21–35 years, with an average of (26.3±3.17) years. No significant difference was observed between the two groups (p>0.05).

Results. The number of cases with postpartum hemorrhage and intrauterine growth restriction in the observation group was less than that in the control group. The total incidence rate was lower than that in the control group. There were significant differences in the above results (p<0.05). The number of patients with preterm birth in the observation group was less than that in the control group, but there was no significant difference in the results (p>0.05). The head circumference, abdominal circumference, biparietal diameter, and femoral length diameter in the control and observation groups increased significantly after treatment (p<0.05). Compared with the control group, the head circumference, abdominal circumference, biparietal diameter, and femoral diameter in the observation group increased more after treatment, and the results were statistically poor (p<0.05). The systolic blood pressure, diastolic blood pressure, and mean arterial pressure in the control and observation groups decreased significantly after treatment, and the results were statistically different (p<0.05). Compared with the control group, the systolic blood pressure, diastolic blood pressure, and mean arterial pressure in the observation group decreased more after treatment. The results were statistically different (p<0.05). The plasma viscosity levels, whole blood high shear viscosity, and whole blood low shear viscosity in the control and observation groups decreased significantly after treatment, and the results were statistically different (p<0.05). Compared with the control group, plasma viscosity levels, whole blood high shear viscosity, and whole blood low shear viscosity in the observation group decreased more after treatment, and the results were statistically different (p<0.05). The control and observation groups’ fetal systolic/diastolic pressure and pulsatile index decreased significantly after treatment, and the results were statistically different (p<0.05). Compared with the control group, the fetal systolic/diastolic blood pressure and pulsatile index in the observation group decreased more after treatment, and the results were statistically poor (p<0.05).

Conclusion. Low-dose aspirin combined with vitamin E is effective in treating intrauterine growth restriction in patients with gestational hypertension. It can effectively control the blood pressure and blood flow of patients and newborns and improve pregnancy outcomes without increasing the incidence of adverse reactions. It is worthy of clinical promotion.

Shan T., Wang P., Fang F. Effects of Low-Dose Aspirin Combined with Vitamin E on the Incidence of Intrauterine Growth Restriction and Hemorheological Indexes of Pregnant Women in Patients with Gestational Hypertension. Comput Math Methods Med. 2022; 2022: 6328807. Published 2022 Feb 21. DOI: https://doi.org/10.1155/2022/6328807

Литература/References

1.Wisner K. Safety bundle for severe hypertension during pregnancy and postpartum. MCN Am J Matern Child Nurs. 2018; 43 (3): 171.

2. Bernstein P.S., Martin J.N., Barton J.R., et al. Consensus bundle on severe hypertension during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 2017; 46 (5): 776–87.

3. Antwi E., Amoakoh-Coleman M., Vieira D.L., et al. Systematic review of prediction models for gestational hypertension and preeclampsia. PLoS One. 2020; 15 (4): e0230955.

4. Braunthal S., Brateanu A. Hypertension in pregnancy: pathophysiology and treatment. SAGE Open Med. 2019; 7: 205031211984370.

5. Butalia S., Audibert F., Cote A.M., et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018; 34 (5): 526–31.

6. Tranquilli A.L., Dekker G., Magee L., et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014; 4 (2): 97–104.

7. Timalsina U., Andrasovich A., Kupferman F.E., Viswanathan K., Ericksen K. Reversal of opioid intoxication in an infant with intrauterine growth restriction with a single dose of naloxone. Cureus. 2021; 13 (10): e18908.

8. Chen C.-P., Lan F.-H., Chern S.-R. et al. Prenatal diagnosis of mosaic trisomy 16 by amniocentesis in a pregnancy associated with abnormal first-trimester screening result (low PAPP-A and low PlGF), intrauterine growth restriction and a favorable outcome. Taiwan J Obstet Gynecol. 2021; 60 (6): 1107–11.

9. Madden J.V., Flatley C.J., Kumar S. Term small-for-gestational-age infants from low-risk women are at significantly greater risk of adverse neonatal outcomes. Am J Obstet Gynecol. 2018; 218 (5): 525–59.

10. Szentpeteri I., Rab A., Kornya L., Kovács P., Brubel R., Joó J.G. Placental gene expression patterns of endoglin (CD105) in intrauterine growth restriction. J Matern Fetal Neonatal Med. 2014; 27 (4): 350–4.

11. Milnerowicz-Nabzdyk E., Bizon A. Effect of cigarette smoking on vascular flows in pregnancies complicated by intrauterine growth restriction. Reprod Toxicol. 2014; 50: 27–35.

12. Martin-Estal I., de la Garza R.G., Castilla-Cortazar I. Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency. Rev Physiol Biochem Pharmacol. 2016; 170: 1–35.

13. Zhu Y.-D., Bian J.-Y., Liao Y.-P., et al. Retrospective validation of 11–13 weeks’ gestation ultrasound characteristics as predictive tools for twin-twin transfusion syndrome and selective intrauterine growth restriction in monochorionic diamniotic twin pregnancies. Ann Transl Med. 2021; 9 (18): 1417.

14. Cyganek A., Pietrzak B., Kociszewska-Najman B., et al. Intrauterine growth restriction in pregnant renal and liver transplant recipients: risk factors assessment. Transplant Proc. 2014; 46 (8): 2794–7.

15. Wallenstein M.B., Harper L.M., Odibo A.O., et al. Fetal congenital heart disease and intrauterine growth restriction: a retrospective cohort study. J Matern Fetal Neonatal Med. 2012; 25 (6): 662–5.

16. Bahtiyar M.O., Copel J.A. Cardiac changes in the intrauterine growth-restricted fetus. Semin Perinatol. 2008; 32 (3): 190–3.

17. Yeste N., Gómez N., Vázquez-Gómez M., et al. Polyphenols and IUGR pregnancies: intrauterine growth restriction and hydroxytyrosol affect the development and neurotransmitter profile of the hippocampus in a pig model. Antioxidants. 2021; 10 (10): 1505.

18. Jaeckle Santos L.J., Li C., Doulias P.T., Ischiropoulos H., Worthen G.S., Simmons R.A. Neutralizing Th2 inflammation in neonatal islets prevents β-cell failure in adult IUGR rats. Diabetes. 2014; 63 (5): 1672–84.

19. Rashid C.S., Lien Y.C., Bansal A., et al. Transcriptomic analysis reveals novel mechanisms mediating islet dysfunction in the intrauterine growth-restricted rat. Endocrinology. 2018; 159 (2): 1035–49.

20. Bahrami R., Schwartz D.A., Karimi-Zarchi M., et al. Meta-analysis of the frequency of intrauterine growth restriction and preterm premature rupture of the membranes in pregnant women with COVID-19. Turk J Obstet Gynecol. 2021; 18 (3): 236–44.

21. Simoncini S., Coppola H., Rocca A., et al. Endothelial colonyforming cells dysfunctions are associated with arterial hypertension in a rat model of intrauterine growth restriction. Int J Mol Sci. 2021; 22 (18): 10159.

22. Benítez-Marín M.J., Marín-Clavijo J., Blanco-Elena J.A., Jiménez-López J., González-Mesa E. Brain sparing effect on neurodevelopment in children with intrauterine growth restriction: a systematic review. Children. 2021; 8 (9): 745.

23. Ferrari F., Ferrari F.A., Negri B., et al. Uterine torsion and intrauterine growth restriction: case report and systematic literature review. J Obstet Gynaecol Res. 2021; 47 (12): 4224–31.

24. Brown A.S., Wieben M., Murdock S., et al. Intrauterine growth restriction causes abnormal embryonic dentate gyrus neurogenesis in mouse offspring that leads to adult learning and memory deficits. eNeuro. 2021; 8 (5): ENEURO.0062-21. 2021.

25. Ornoy A., Tsadok M.A., Yaffe P., Zangen S.W. The Cohen diabetic rat as a model for fetal growth restriction: vitamins C and E reduce fetal oxidative stress but do not restore normal growth. Reprod Toxicol. 2009; 28 (4): 521–9.

26. Gäreskog M., Eriksson U.J., Wentzel P. Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats. Birth Defects Res Pt A Clin Mol Teratol. 2006; 76 (6): 483–90.

27. Hafez S.M.N.A., Elbassuoni E., Abdelzaher W.Y., et al. Efficacy of vitamin E in protection against methotrexate induced placental injury in albino rats. Biomed Pharmacother. 2021; 139: 111637.

28. Bujold E., Roberge S., Lacasse Y., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy. Obstet Gynecol. 2010; 116 (2): 402–14.

29. Roberge S., Odibo A.O., Bujold R. Aspirin for the prevention of preeclampsia and intrauterine growth restriction. Clin Lab Med. 2016; 36 (2): 319–29.

CHIEF EDITORS
CHIEF EDITOR
Sukhikh Gennadii Tikhonovich
Academician of the Russian Academy of Medical Sciences, V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Healthсаre of the Russian Federation, Moscow
CHIEF EDITOR
Savel'eva Galina Mikhailovna
Academician of the Russian Academy of Sciences, MD, Professor, Head of the Subdepartment of Obstetrics and Gynecology of the Pediatric Department of the N.I. Pirogov Russian National Scientific Research Medical University under the Ministry of Health of Russia
CHIEF EDITOR
Radzinsky Viktor Evseevich
Corresponding Member of the Russian Academy of Sciences, MD, Professor, Head of the Subdepartment of Obstetrics and Gynecology with a Course of Perinatology of the Medical Department in the Russian People?s Friendship University
Конгресс Право на жизнь
Вскрытие
Medicine today

Уважаемые коллеги! Представляем оргкомитет 17-го Национального конгресса терапевтов (с международным участием) , который состоится 12-14 октября в МВЦ "Крокус Экспо" (павильон 3, Зал 20, г. Москва). · Президент Российского научного медицинского общества терапевтов,...

IV Съезд онкологов Московской области 7 октября 2022 года Активное развитие онкологической службы позволяет эффективно решать проблемы, возникающие на всех уровнях оказания помощи пациентам с онкозаболеваниями. Одним из успешных примеров такого взаимодействия является IV...

II Всероссийская конференция с международным участием "Воспаление глаза" 12 ноября 2022 года, Москва Воспалительные заболевания глаза - широко распространенная и многогранная проблема, с которой может столкнуться в своей практике любой специалист. Найти оптимальные алгоритмы...


Journals of «GEOTAR-Media»